Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression

Etienne Becht1,2,3,4, Nicolas A Giraldo1,2,3, Laetitia Lacroix1,2,3

  • 1INSERM UMR_S 1138, Cancer, Immune Control and Escape, Cordeliers Research Centre, Paris, France.

Genome Biology
|October 22, 2016
PubMed

Insights

We developed Microenvironment Cell Populations-counter (MCP-counter) to quantify immune and stromal cells from gene expression data. This method accurately estimates cell abundance and improves upon existing computational approaches for cancer research.

Area of Science:

  • Bioinformatics
  • Immunology
  • Computational Biology

Background:

  • Accurate quantification of immune and stromal cells in tumor microenvironments is crucial for understanding cancer progression and treatment response.
  • Existing computational methods for estimating cell populations from transcriptomic data have limitations.

Purpose of the Study:

  • To introduce and validate the Microenvironment Cell Populations-counter (MCP-counter) method for robustly quantifying cell populations from transcriptomic data.
  • To compare MCP-counter with existing computational approaches and highlight its advantages.

Main Methods:

  • Development of the MCP-counter algorithm utilizing transcriptomic data.
  • Validation using in vitro mRNA mixtures and ex vivo immunohistochemical data.
  • Application to analyze immune infiltrates in human healthy tissues and tumors.

Main Results:

  • MCP-counter accurately quantifies eight immune and two stromal cell populations.
  • The method demonstrates superior performance compared to previous computational approaches.
  • Analysis of human tissues revealed distinct immune infiltration patterns in tumors and recapitulated survival-associated patient stratifications.

Conclusions:

  • MCP-counter provides a robust and validated method for estimating cell populations from transcriptomic data.
  • The tool offers valuable insights into the tumor microenvironment and its impact on patient survival.
  • MCP-counter facilitates large-scale analysis of immune infiltrates across diverse human tissues and cancers.

Related Concept Videos